| Literature DB >> 24944746 |
Vivek Kumar1, Troels Rahbek-Clemmensen2, Christian B Billesbølle2, Trine Nygaard Jorgensen2, Ulrik Gether2, Amy Hauck Newman1.
Abstract
Novel rhodamine-labeled ligands, based on (S)-citalopram, were synthesized and evaluated for uptake inhibition at the human serotonin, dopamine, and norepinephrine transporters (hSERT, hDAT, and hNET, respectively) and for binding at SERT, in transiently transfected COS7 cells. Compound 14 demonstrated high affinity binding and selectivity for SERT (K i = 3 nM). Visualization of SERT, using confocal laser scanning microscopy, validated compound 14 as a novel tool for studying SERT expression and distribution in living cells.Entities:
Keywords: Fluorescent ligand; SERT; citalopram; rhodamine
Year: 2014 PMID: 24944746 PMCID: PMC4060933 DOI: 10.1021/ml5000806
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345